Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.86	124.33	65.4	193.99	295.18	243.14
Cash & Short-Term Investments	5.86	124.33	65.4	193.99	295.18	243.14
Cash Growth	-91.95%	90.10%	-66.29%	-34.28%	21.40%	48.08%
Accounts Receivable	5.87	16.85	-	1.34	-	51.38
Other Receivables	19.73	76.01	71.18	46.12	108.3	23.79
Receivables	25.6	92.87	71.18	47.46	108.3	75.17
Inventory	214.91	246.9	106.86	50.26	-	-
Prepaid Expenses	118.87	8.07	16.89	13	2.31	1.21
Other Current Assets	1.18	133.73	201.37	208.81	155.21	54.96
Total Current Assets	366.43	605.9	461.69	513.52	561.01	374.48
Property, Plant & Equipment	0.15	64.9	88.2	71.05	73.8	14.14
Goodwill	-	-	-	-	-	58.45
Long-Term Deferred Charges	235.21	167.69	99.67	102	49.67	4.08
Other Long-Term Assets	-	3.95	3.95	3.95	3.95	12.61
Total Assets	601.79	842.43	653.51	690.52	688.43	463.76
Accounts Payable	112.45	242.57	30.97	23.3	41.39	29.55
Accrued Expenses	80.73	41.19	140.89	66.48	65.76	41.22
Current Portion of Long-Term Debt	20	82.5	62.5	-	-	-
Current Portion of Leases	-	13.27	13.37	9.16	7.91	2.27
Current Unearned Revenue	-	147.26	75.41	136.06	95.39	115.96
Other Current Liabilities	3.72	11.15	3.42	1.56	9.22	0
Total Current Liabilities	216.9	537.94	326.56	236.57	219.67	188.99
Long-Term Debt	-	66.37	112.9	-	-	-
Long-Term Leases	-	29.58	42.71	29.06	36.48	4
Long-Term Unearned Revenue	-	-	-	-	0.54	8.26
Other Long-Term Liabilities	-0	-0	0.01	-	-	4.81
Total Liabilities	216.9	633.89	482.17	265.63	256.69	206.06
Common Stock	343.5	343.5	6.68	6.17	5.61	4.98
Additional Paid-In Capital	1,394	1,395	1,429	1,294	1,134	773.72
Retained Earnings	-1,362	-1,540	-1,274	-885.83	-713.31	-524.94
Comprehensive Income & Other	10.16	10.23	10.12	10.32	5.16	3.95
Shareholders' Equity	384.89	208.54	171.34	424.89	431.74	257.71
Total Liabilities & Equity	601.79	842.43	653.51	690.52	688.43	463.76
Total Debt	20	191.72	231.48	38.22	44.38	6.26
Net Cash (Debt)	-14.14	-67.39	-166.08	155.77	250.8	236.88
Net Cash Growth	-	-	-	-37.89%	5.88%	53.06%
Net Cash Per Share	-0.01	-0.05	-5.79	6.09	10.63	13.08
Filing Date Shares Outstanding	1,532	1,529	29.81	27.51	25.04	22.2
Total Common Shares Outstanding	1,532	1,529	29.81	27.51	25.04	22.2
Working Capital	149.53	67.96	135.14	276.96	341.34	185.49
Book Value Per Share	0.25	0.14	5.75	15.45	17.24	11.61
Tangible Book Value	384.89	208.54	171.34	424.89	431.74	199.26
Tangible Book Value Per Share	0.25	0.14	5.75	15.45	17.24	8.98
Machinery	-	62.43	61.93	-	43.49	28.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.